参考文献/References:
[1] Wang A, Green JB, Halperin JL, et al. Atrial fibrillation and diabetes mellitus[J]. J Am Coll Cardiol,2019,74(8):1107-1115.
[2] Kumar N, Echouffo-Tcheugui JB. Diabetes and atrial fibrillation in hospitalized patients in the United States[J]. Clin Cardiol,2021,44(3):340-348.
[3] Anselmino M, Matta M, D’Ascenzo F, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis[J]. Europace,2015,17(10):1518-1525.
[4] Gilbert RE, Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy[J]. Lancet,2015,385(9982):2107-2117.
[5] Goudis CA, Korantzopoulos P, Ntalas IV, et al. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies[J]. Int J Cardiol,2015,184:617-622.
[6] 顾俊，胡伟，刘旭. 心房重构研究进展[J]. 国际心血管病杂志,2014,41(6):398-401.
[7] Nso N, Bookani KR, Metzl M, et al. Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge[J]. J Arrhythm,2021,37(1):1-10.
[8] 卢振华，范莹，胡家顺，等. 糖尿病并发心房颤动机制的研究进展[J]. 心肺血管病杂志,2017,36(3):234-236.
[9] 王红丽，李志强，周贤惠，等. 肌浆网钙ATP酶过表达对心房颤动兔心房心电生理的影响[J]. 中华临床医师杂志(电子版),2014,8(16):2997-3001.
[10] 吴丹丹，陈瑜，张腾. 房颤发病机制研究新进展[J]. 中西医结合心脑血管病杂志,2016,14(12):1342-1346.
[11] 付茜，潘一龙，李斌，等. 糖尿病源性心房颤动——心房电重构的研究进展[J]. 中国实用内科杂志,2018,38(7):658-661.
[12] 高秋实，郝丽英，赵美眯. 钙调蛋白信号转导途径的机制及其对心律失常的影响[J]. 解剖科学进展,2016,22(4):455-458.
[13] Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycaemia activates CaMKⅡ and arrhythmias by O-linked glycosylation[J]. Nature,2013,502(7471):372-376.
[14] Wang X, Chen X, Dobrev D, et al. The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation[J]. Pflugers Arch,2021,473(3):389-405.
[15] Hamilton S, Veress R, Belevych A, et al. The role of calcium homeostasis remodeling in inherited cardiac arrhythmia syndromes[J]. Pflugers Arch,2021,473(3):377-387.
[16] Huang W, Wang Y, Cao YG, et al. Antiarrhythmic effects and ionic mechanisms of allicin on myocardial injury of diabetic rats induced by streptozotocin[J]. Naunyn Schmiedebergs Arch Pharmacol,2013,386(8):697-704.
[17] Sommese L, Valverde C A, Blanco P, et al. Ryanodine receptor phosphorylation by CaMKⅡ promotes spontaneous Ca (2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate[J]. Int J Cardiol,2016,202:394-406.
[18] Hegyi B, Bers DM, Bossuyt J. CaMKⅡ signaling in heart diseases: emerging role in diabetic cardiomyopathy[J]. J Mol Cell Cardiol,2019,127:246-259.
[19] Vafiadaki E, Papalouka V, Arvanitis DA, et al. The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate[J]. Pflugers Arch,2009,457(3):687-700.
[20] Dillmann WH. Diabetic Cardiomyopathy[J]. Circ Res,2019,124(8):1160-1162.
[21] Lombardi M, Lazzeroni D, Pisano A, et al. Mitochondrial energetics and Ca2+-activated ATPase in obstructive hypertrophic cardiomyopathy[J]. J Clin Med,2020,9(6):1799.
[22] Shao CH, Capek HL, Patel KP, et al. Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes[J]. Diabetes,2011,60(3):947-959.
[23] Pereira L, Ruiz-Hurtado G, Rueda A, et al. Calcium signaling in diabetic cardiomyocytes[J]. Cell Calcium,2014,56(5):372-380.
[24] Mesubi OO, Anderson ME. Atrial remodelling in atrial fibrillation: CaMKⅡ as a nodal proarrhythmic signal[J]. Cardiovasc Res,2016,109(4):542-557.
[25] Brundel BJ, Ausma J, van Gelder IC, et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation[J]. Cardiovasc Res,2002,54(2):380-389.
[26] 张若愚. 2型糖尿病及其药物对心房颤动的影响[J]. 心血管病学进展,2016,37(4):337-341.
[27] Yuan Y, Zhao J, Gong Y, et al. Autophagy exacerbates electrical remodeling in atrial fibrillation by ubiquitin-dependent degradation of L-type calcium channel[J]. Cell Death Dis,2018,9(9):873.
[28] Kura B, Kalocayova B, Devaux Y, et al. Potential clinical implications of miR-1 and miR-21 in heart disease and cardioprotection[J]. Int J Mol Sci,2020,21(3):700.
[29] 孙红云，赵琪，王淑颜，等. microRNA对心脏离子通道调控作用的研究进展[J]. 世界临床药物,2016,37(12):840-845.
[30] Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications[J]. Cardiovasc Res,2012,93(4):583-593.
[31] Belevych AE, Sansom SE, Terentyeva R, et al. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex[J]. PLoS One,2011,6(12):e28324.
[32] Barana A, Matamoros M, Dolz-Gaitón P, et al. Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current[J]. Circ Arrhythm Electrophysiol,2014,7(5):861-868.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(10):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(10):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]张若愚,综述,殷跃辉,等.2型糖尿病及其药物对心房颤动的影响[J].心血管病学进展,2016,(4):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
ZHANG Ruoyu,YIN Yuehui.Effect of Type 2 Diabetes Mellitus and Diabetic Drugs on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
[8]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(10):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[9]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(10):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[10]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(10):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[11]夏熠 刘飞 夏云龙.糖尿病合并心房颤动的相关研究进展[J].心血管病学进展,2020,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]
XIA YiLIU FeiXIA Yunlong.Research Progress in Diabetes Mellitus Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(10):27.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.008]